Home > Publications Database > The Alzheimer's disease-linked protease BACE2 cleaves VEGFR3 and modulates its signaling. |
Journal Article | DZNE-2024-01041 |
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
2024
ASCJ
Ann Arbor, Mich.
This record in other databases:
Please use a persistent id in citations: doi:10.1172/JCI170550
Abstract: The β-secretase β-site APP cleaving enzyme (BACE1) is a central drug target for Alzheimer's disease. Clinically tested, BACE1-directed inhibitors also block the homologous protease BACE2. Yet little is known about physiological BACE2 substrates and functions in vivo. Here, we identify BACE2 as the protease shedding the lymphangiogenic vascular endothelial growth factor receptor 3 (VEGFR3). Inactivation of BACE2, but not BACE1, inhibited shedding of VEGFR3 from primary human lymphatic endothelial cells (LECs) and reduced release of the shed, soluble VEGFR3 (sVEGFR3) ectodomain into the blood of mice, nonhuman primates, and humans. Functionally, BACE2 inactivation increased full-length VEGFR3 and enhanced VEGFR3 signaling in LECs and also in vivo in zebrafish, where enhanced migration of LECs was observed. Thus, this study identifies BACE2 as a modulator of lymphangiogenic VEGFR3 signaling and demonstrates the utility of sVEGFR3 as a pharmacodynamic plasma marker for BACE2 activity in vivo, a prerequisite for developing BACE1-selective inhibitors for safer prevention of Alzheimer's disease.
Keyword(s): Amyloid Precursor Protein Secretases: metabolism (MeSH) ; Amyloid Precursor Protein Secretases: genetics (MeSH) ; Amyloid Precursor Protein Secretases: antagonists & inhibitors (MeSH) ; Animals (MeSH) ; Aspartic Acid Endopeptidases: metabolism (MeSH) ; Aspartic Acid Endopeptidases: genetics (MeSH) ; Aspartic Acid Endopeptidases: antagonists & inhibitors (MeSH) ; Humans (MeSH) ; Mice (MeSH) ; Vascular Endothelial Growth Factor Receptor-3: metabolism (MeSH) ; Vascular Endothelial Growth Factor Receptor-3: genetics (MeSH) ; Signal Transduction (MeSH) ; Zebrafish: metabolism (MeSH) ; Zebrafish: genetics (MeSH) ; Alzheimer Disease: metabolism (MeSH) ; Alzheimer Disease: genetics (MeSH) ; Alzheimer Disease: pathology (MeSH) ; Alzheimer Disease: enzymology (MeSH) ; Endothelial Cells: metabolism (MeSH) ; Endothelial Cells: enzymology (MeSH) ; Endothelial Cells: pathology (MeSH) ; Zebrafish Proteins: genetics (MeSH) ; Zebrafish Proteins: metabolism (MeSH) ; Aging ; Alzheimer disease ; Drug therapy ; Amyloid Precursor Protein Secretases ; Aspartic Acid Endopeptidases ; Vascular Endothelial Growth Factor Receptor-3 ; BACE2 protein, human ; FLT4 protein, human ; Bace2 protein, mouse ; Zebrafish Proteins ; BACE1 protein, human
![]() |
The record appears in these collections: |
Dataset
Dataset: Plasma proteomics of mice treated with BACE inhibitors
PRoteomics IDEntifications Database (2024)
Fulltext
BibTeX |
EndNote:
XML,
Text |
RIS
Dataset
Dataset: Plasma proteomics of BACE2 KO mice
PRoteomics IDEntifications Database (2024)
Fulltext
BibTeX |
EndNote:
XML,
Text |
RIS
Dataset
Dataset: Plasma proteomics of BACE1, 2, and double KO mice
PRoteomics IDEntifications Database (2024)
Fulltext
BibTeX |
EndNote:
XML,
Text |
RIS